Active Ingredient History
Gadopentetic acid, sold under the brand name Magnevist, is a gadolinium-based MRI contrast agent. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Diagnostic Imaging (approved 1988)
Aortic Diseases (Phase 3)
Astrocytoma (Early Phase 1)
Brain Neoplasms (Phase 4)
Breast Neoplasms (Phase 4)
Cardiovascular Abnormalities (Phase 3)
Central Nervous System Diseases (Phase 3)
Constriction, Pathologic (Phase 3)
Diagnostic Self Evaluation (Phase 3)
Ependymoma (Early Phase 1)
Fibrosis (Phase 4)
Glioblastoma (Early Phase 1)
Gliosarcoma (Early Phase 1)
Healthy Volunteers (Phase 1)
Heart Defects, Congenital (Phase 1)
Hypertension, Pulmonary (Phase 1)
Liver Neoplasms (Phase 2)
Magnetic Resonance Angiography (Phase 2)
Magnetic Resonance Imaging (Phase 4)
Myocardial Infarction (Phase 2)
Neoplasms (Phase 2)
Oligodendroglioma (Early Phase 1)
Peripheral Arterial Disease (Phase 2)
Peripheral Vascular Diseases (Phase 3)
Positron-Emission Tomography (Phase 4)
Renal Artery Obstruction (Phase 3)
Renal Insufficiency (Phase 4)
Shoulder Injuries (Phase 4)
Vascular Diseases (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue